Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

Strut Health Tirzepatide Review: Cost, the Oral Route & Honest Verdict (2026)

An honest 2026 review of Strut Health for tirzepatide — the real $199/month price, why the oral lozenge isn't freely optional, and the catches.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

FDA warning letter
FDA issued Strut Health, LLC dba Strut a warning letter in February 2026 (False & Misleading Claims/Misbranded (Telehealth)). Read the letter on FDA’s own warning-letter database.

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$120/mo below the $269 median
Market
$109–$429/mo across 396 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

SkinnyRx

A compounded tirzepatide TABLET at the same price as the injection — but the advertised $299 is the twelve-month rate, not the monthly one.

$399/mo ($299 on a 12-month plan)

FDA warning letter
FDA issued Lean Rx, Inc. dba SkinnyRx a warning letter in February 2026 (False & Misleading Claims/Misbranded (Telehealth)). Read the letter on FDA’s own warning-letter database.

Check SkinnyRx availability

Strut Health is an asynchronous compounded telehealth prescriber offering tirzepatide as either a weekly injection or an oral lozenge, both listed at the same $199/month starting price. The genuine differentiator is route — most competitors in this category only inject — but the oral lozenge is not a free choice the way it first appears: Strut's own product page states it is available only for patients who fail or cannot use a GLP-1 injection, with medical necessity required. That's a real, worth-knowing correction to the idea that the needle is simply optional here. Every fact here comes from the company's own published program.

What Strut Health is

Strut Health is an asynchronous prescriber: a U.S.-licensed physician reviews your intake online, typically within a business day, and in many states no live phone or video consultation is required at all. It offers tirzepatide two ways — a once-weekly compounded injection and an oral lozenge that dissolves in the mouth — both at the same $199/month starting price. Free physician review, free shipping and free follow-up care are included in that price rather than added at checkout, and the site states plans can be canceled, paused, or delayed.

The oral route isn't a free choice — read this before assuming it's optional

Strut's own oral tirzepatide product page states, and verbatim: "Only available for patients that fail or cannot use a GLP-1 injection. Medical Necessity Required." The identical language appears on the injectable page too, framed as a general compounded-medication disclaimer — but on the oral product specifically, it functions as an actual eligibility gate: you generally need to have tried and failed the injection, or have a documented reason you can't use it, before Strut will prescribe the lozenge. That means the needle is not simply optional for anyone who'd prefer to avoid it — it's the default route, with the oral lozenge reserved for people the injection doesn't work for. Both routes are priced identically at $199/month, on each product's own page, so the price parity itself holds; it's the access that's conditional, not the cost.

§ Strut Health — Route Access, Not Just Price

RoutePriceAccess
Injectable tirzepatide$199/monthDefault route, no stated restriction
Oral lozenge$199/monthRequires documented medical necessity (failed or can't use injection)
Both routes are priced the same at $199/month, on each product page — but the oral lozenge is gated behind a 'fail or cannot use injection' requirement, not a free preference.

What Strut Health costs in 2026

Both the injectable and oral tirzepatide products start at $199/month, directly on each product page, described as auto-refill pricing. Free physician review, free shipping, and free follow-up care are bundled into that figure rather than billed separately. The site states plans can be canceled, paused, or delayed by the patient.

The brand-vs-compounded question

Strut Health dispenses compounded tirzepatide, not the FDA-approved branded product (Mounjaro or Zepbound). Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture, and our Zepbound cost and savings guide if you want the branded benchmark.

How the care model holds up

Strut's real strengths: price parity between the injection and the oral route at $199/month, a genuinely asynchronous model that in many states requires no live consultation, and free physician review, shipping, and follow-up care bundled into the headline price. The trade-off worth internalizing: the oral lozenge requires documented medical necessity — failing or being unable to use the injection — so it is not a needle-free option available to anyone who simply prefers to avoid injecting. And the asynchronous model itself means, in many states, you will never speak live to the prescriber before your prescription is written. As with any GLP-1 program, confirm your state's specific requirements and read the cancellation terms directly; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

FDA warning letter, February 2026

FDA issued Strut Health, LLC dba Strut a warning letter in February 2026, posted under the subject line False & Misleading Claims/Misbranded (Telehealth)3. We independently confirmed it against FDA's own published warning-letter record rather than repeating a second-hand report, and the reference at the foot of this page links straight to FDA's copy.

We are not going to paraphrase FDA's findings back to you — the letter is short, it is public, and reading the agency's own words beats reading ours. What matters for how you use this page is that the letter exists, that it is recent, and that we are telling you about it while still linking to Strut on commission. The affiliate relationship has not changed and the ranking has not been quietly adjusted around it; the notice travels with Strut on every ranking, index and card where we link to the company, not just here.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Strut Health is a solid pick if you want a genuinely asynchronous prescribing model with free follow-up care bundled in at a competitive $199/month — but go in expecting to start on the injection. The oral lozenge is a real option for people the needle doesn't work for, not a preference-based alternative available on request. If you specifically want a needle-free route without a medical-necessity requirement, that's worth confirming directly with Strut before signing up, or comparing against Shed, which offers GLP-1 drops and lozenges as a stated format choice rather than a fallback. If an all-in, no-charge-until-approved price structure matters more than route flexibility, see Breeze Meds; if named pharmacies matter more, weigh MyDrHank instead; and if a named, accredited pharmacy paired with flat dose pricing appeals to you, compare Aspen — just read its 3-month minimum commitment first. See our best tirzepatide providers ranking for the full field.

Frequently asked questions

How much does tirzepatide cost through Strut Health?

Both the injectable and oral tirzepatide products start at $199/month, directly on each product page — free physician review, shipping, and follow-up care are included in that figure.

Can I choose the oral tirzepatide lozenge instead of the injection at Strut Health?

Not freely. Strut Health's own oral tirzepatide product page states, and verbatim, that it's 'only available for patients that fail or cannot use a GLP-1 injection. Medical Necessity Required.' The injection is the default route; the oral lozenge is reserved for people the injection doesn't work for, not a preference-based alternative.

Does Strut Health require a video consultation?

Not necessarily. Strut Health is an asynchronous prescriber — a licensed physician reviews your intake online, typically within a business day, and in many states no live phone or video call is required before a prescription is written.

Does Strut Health offer brand-name tirzepatide?

No. Strut Health dispenses compounded tirzepatide only — no brand-name Zepbound or Mounjaro pathway was found on the pages this review read.

Has Strut Health received an FDA warning letter?

Yes. FDA issued Strut Health, LLC dba Strut a warning letter in February 2026, posted under the subject line 'False & Misleading Claims/Misbranded (Telehealth).' We independently confirmed it against FDA's own published record, and the reference list on this page links to the letter so you can read the agency's own words rather than our summary of them. We still link to Strut on commission and disclose the letter wherever we do.

References(3)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. https://pubmed.ncbi.nlm.nih.gov/40353578/
  3. U.S. Food and Drug Administration (2026). Warning Letter — Strut Health, LLC dba Strut (MARCS-CMS 721448): False & Misleading Claims/Misbranded (Telehealth).. FDA Warning Letters. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/strut-health-llc-dba-strut-721448-02202026

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated August 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.